These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 18480682)

  • 1. A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia.
    Yuan HN; Wang CY; Sze CW; Tong Y; Tan QR; Feng XJ; Liu RM; Zhang JZ; Zhang YB; Zhang ZJ
    J Clin Psychopharmacol; 2008 Jun; 28(3):264-370. PubMed ID: 18480682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Not only dopamine D2 receptors involved in Peony-Glycyrrhiza Decoction, an herbal preparation against antipsychotic-associated hyperprolactinemia.
    Wang D; Wong HK; Zhang L; McAlonan GM; Wang XM; Sze SC; Feng YB; Zhang ZJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):332-8. PubMed ID: 22796279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peony-Glycyrrhiza Decoction for Antipsychotic-Related Hyperprolactinemia in Women With Schizophrenia: A Randomized Controlled Trial.
    Man SC; Li XB; Wang HH; Yuan HN; Wang HN; Zhang RG; Tan QR; Wong HK; McAlonan GM; Wang CY; Zhang ZJ
    J Clin Psychopharmacol; 2016 Dec; 36(6):572-579. PubMed ID: 27755159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the regulatory effect of Peony-Glycyrrhiza Decoction on prolactin hyperactivity and underlying mechanism in hyperprolactinemia rat model.
    Wang D; Wang W; Zhou Y; Wang J; Jia D; Wong HK; Zhang ZJ
    Neurosci Lett; 2015 Oct; 606():60-5. PubMed ID: 26297122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic-associated hyperprolactinemia. Can it be treated with bromocriptine?
    Smith S
    J Reprod Med; 1992 Aug; 37(8):737-40. PubMed ID: 1359137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bromocriptine on antipsychotic drug-induced hyperprolactinemia: eight-week randomized, single-blind, placebo-controlled, multicenter study.
    Lee MS; Song HC; An H; Yang J; Ko YH; Jung IK; Joe SH
    Psychiatry Clin Neurosci; 2010 Feb; 64(1):19-27. PubMed ID: 19968833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study.
    Chen JX; Su YA; Bian QT; Wei LH; Zhang RZ; Liu YH; Correll C; Soares JC; Yang FD; Wang SL; Zhang XY
    Psychoneuroendocrinology; 2015 Aug; 58():130-40. PubMed ID: 25981348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
    Lu ML; Shen WW; Chen CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
    Segal M; Avital A; Derevenski A; Berstein S; Sandbank S; Weizman A
    Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the dopamine agonists bromocriptine and cabergoline in the management of risperidone-induced hyperprolactinemia in patients with psychotic disorders.
    Tollin SR
    J Endocrinol Invest; 2000 Dec; 23(11):765-70. PubMed ID: 11194712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia.
    Yasui-Furukori N; Furukori H; Sugawara N; Fujii A; Kaneko S
    J Clin Psychopharmacol; 2010 Oct; 30(5):596-9. PubMed ID: 20814333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of neuroleptic-induced hyperprolactinemia on sexual dysfunction in male schizophrenic patients].
    Konarzewska B; Szulc A; Popławska R; Galińska B; Juchnowicz D
    Psychiatr Pol; 2008; 42(1):87-95. PubMed ID: 18567406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Add-on effects of a low-dose aripiprazole in resolving hyperprolactinemia induced by risperidone or paliperidone.
    Qiao Y; Yang F; Li C; Guo Q; Wen H; Zhu S; Ouyang Q; Shen W; Sheng J
    Psychiatry Res; 2016 Mar; 237():83-9. PubMed ID: 26921057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of compound xuanju capsule combined with bromocriptine on hyperprolactinemia-induced erectile dysfunction].
    Bian J; Liu CD; Sun XZ; Deng CH; Huang YP; Ye YL
    Zhonghua Nan Ke Xue; 2012 Nov; 18(11):1023-7. PubMed ID: 23214255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone.
    Kinon BJ; Gilmore JA; Liu H; Halbreich UM
    Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():55-68. PubMed ID: 12650681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switch to quetiapine in antipsychotic agent-related hyperprolactinemia.
    Keller R; Mongini F
    Neurol Sci; 2002 Dec; 23(5):233-5. PubMed ID: 12522680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cabergoline on hyperprolactinemia, psychopathology, and sexual functioning in schizophrenic patients.
    Kalkavoura CS; Michopoulos I; Arvanitakis P; Theodoropoulou P; Dimopoulou K; Tzebelikos E; Lykouras L
    Exp Clin Psychopharmacol; 2013 Aug; 21(4):332-41. PubMed ID: 23834553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of psychotropic-induced hyperprolactinemia.
    Marken PA; Haykal RF; Fisher JN
    Clin Pharm; 1992 Oct; 11(10):851-6. PubMed ID: 1341991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
    Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.